|
|
|
Insider
Information: |
Scott Randal W |
Relationship: |
Director |
City: |
Redwood City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
1,371,339 |
|
Indirect Shares
|
1,782,329 |
|
|
Direct
Value |
$75,300,787 |
|
|
Indirect Value
|
$1,093,612 |
|
|
Total
Shares |
3,153,668 |
|
|
Total
Value |
$76,394,399 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
Percentage
Gain/Loss : |
-22.7%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
![](../../../Gifs/iconPlus.jpg) |
Genomic Health Inc |
GHDX |
CEO, InVitae Corporati... |
2012-07-11 |
1,185,117 |
2012-07-11 |
15,764 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Invitae Corp |
NVTA |
Director |
2023-04-27 |
161,222 |
2023-04-27 |
60,000 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Bridgebio Pharma, Inc. |
BBIO |
|
2024-06-04 |
5,000 |
2024-06-04 |
4,000 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Talis Biomedical Corp |
TLIS |
Director |
2021-05-17 |
20,000 |
2021-05-17 |
1,702,565 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
160 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GHDX |
Genomic Health Inc |
Chief Executive Officer |
|
2008-05-12 |
4 |
AS |
$18.81 |
$112,864 |
D/D |
(6,000) |
2,045,298 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Executive Officer |
|
2008-05-13 |
4 |
AS |
$18.69 |
$112,111 |
D/D |
(6,000) |
2,039,298 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Executive Officer |
|
2008-06-09 |
4 |
AS |
$20.01 |
$120,032 |
D/D |
(6,000) |
2,033,298 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Executive Officer |
|
2008-06-10 |
4 |
AS |
$19.83 |
$118,972 |
D/D |
(6,000) |
2,027,298 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Executive Officer |
|
2008-07-14 |
4 |
AS |
$20.81 |
$124,838 |
D/D |
(6,000) |
2,021,298 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Executive Officer |
|
2008-07-15 |
4 |
AS |
$21.19 |
$127,167 |
D/D |
(6,000) |
2,015,298 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Executive Officer |
|
2008-08-11 |
4 |
AS |
$23.58 |
$141,483 |
D/D |
(6,000) |
2,009,298 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Executive Officer |
|
2008-08-12 |
4 |
AS |
$23.93 |
$143,590 |
D/D |
(6,000) |
2,003,298 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Executive Officer |
|
2008-09-15 |
4 |
AS |
$21.76 |
$130,531 |
D/D |
(6,000) |
1,997,298 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Executive Officer |
|
2008-09-16 |
4 |
AS |
$21.83 |
$131,003 |
D/D |
(6,000) |
1,991,298 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Executive Officer |
|
2008-10-13 |
4 |
AS |
$19.80 |
$118,812 |
D/D |
(6,000) |
1,985,298 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Executive Officer |
|
2008-10-14 |
4 |
AS |
$20.90 |
$125,500 |
D/D |
(6,000) |
1,979,298 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Executive Officer |
|
2008-11-10 |
4 |
AS |
$20.19 |
$121,151 |
D/D |
(6,000) |
1,973,298 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Executive Officer |
|
2008-11-11 |
4 |
AS |
$19.92 |
$119,493 |
D/D |
(6,000) |
1,967,298 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Executive Officer |
|
2008-12-08 |
4 |
AS |
$18.00 |
$107,977 |
D/D |
(6,000) |
1,961,298 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Executive Officer |
|
2008-12-09 |
4 |
AS |
$18.81 |
$112,843 |
D/D |
(6,000) |
1,955,298 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Executive Officer |
|
2008-12-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
30,000 |
1,925,298 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Chief Executive Officer |
|
2008-12-29 |
4 |
OE |
$3.17 |
$219,833 |
D/D |
69,348 |
1,994,646 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Director |
|
2020-06-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
% |
|
TLIS |
Talis Biomedical Corp |
Director |
|
2021-02-17 |
4 |
B |
$16.00 |
$5,000,000 |
I/I |
312,500 |
312,500 |
2.1 |
- |
|
TLIS |
Talis Biomedical Corp |
Director |
|
2021-02-17 |
4 |
A |
$0.00 |
$0 |
I/I |
1,390,064 |
1,390,064 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Director |
|
2021-02-17 |
4 |
B |
$62.50 |
$1,000,000 |
D/D |
16,000 |
21,000 |
2.39 |
% |
|
TLIS |
Talis Biomedical Corp |
Director |
|
2021-05-14 |
4 |
B |
$10.16 |
$91,440 |
D/D |
9,000 |
9,000 |
2.39 |
- |
|
TLIS |
Talis Biomedical Corp |
Director |
|
2021-05-17 |
4 |
B |
$10.11 |
$111,210 |
D/D |
11,000 |
20,000 |
2.39 |
- |
|
NVTA |
Invitae Corp |
Director |
|
2022-07-16 |
4 |
A |
$0.00 |
$0 |
D/D |
53,800 |
90,800 |
0 |
- |
|
160 Records found
|
|
Page 3 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|